Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System
©2020 American Association for Cancer Research..
Patients with cancer are presumed to be at increased risk from COVID-19 infection-related fatality due to underlying malignancy, treatment-related immunosuppression, or increased comorbidities. A total of 218 COVID-19-positive patients from March 18, 2020, to April 8, 2020, with a malignant diagnosis were identified. A total of 61 (28%) patients with cancer died from COVID-19 with a case fatality rate (CFR) of 37% (20/54) for hematologic malignancies and 25% (41/164) for solid malignancies. Six of 11 (55%) patients with lung cancer died from COVID-19 disease. Increased mortality was significantly associated with older age, multiple comorbidities, need for ICU support, and elevated levels of D-dimer, lactate dehydrogenase, and lactate in multivariate analysis. Age-adjusted CFRs in patients with cancer compared with noncancer patients at our institution and New York City reported a significant increase in case fatality for patients with cancer. These data suggest the need for proactive strategies to reduce likelihood of infection and improve early identification in this vulnerable patient population. SIGNIFICANCE: COVID-19 in patients with cancer is associated with a significantly increased risk of case fatality, suggesting the need for proactive strategies to reduce likelihood of infection and improve early identification in this vulnerable patient population.This article is highlighted in the In This Issue feature, p. 890.
| Errataetall: |
CommentIn: Radiother Oncol. 2021 Aug;161:148-151. - PMID 34118358 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
Cancer discovery - 10(2020), 7 vom: 01. Juli, Seite 935-941 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Mehta, Vikas [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 20.07.2020 Date Revised 05.10.2022 published: Print-Electronic CommentIn: Radiother Oncol. 2021 Aug;161:148-151. - PMID 34118358 Citation Status MEDLINE |
|---|
| doi: |
10.1158/2159-8290.CD-20-0516 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM309416558 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM309416558 | ||
| 003 | DE-627 | ||
| 005 | 20231226201407.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1158/2159-8290.CD-20-0516 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1031.xml |
| 035 | |a (DE-627)NLM309416558 | ||
| 035 | |a (NLM)32357994 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Mehta, Vikas |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 20.07.2020 | ||
| 500 | |a Date Revised 05.10.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: Radiother Oncol. 2021 Aug;161:148-151. - PMID 34118358 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a ©2020 American Association for Cancer Research. | ||
| 520 | |a Patients with cancer are presumed to be at increased risk from COVID-19 infection-related fatality due to underlying malignancy, treatment-related immunosuppression, or increased comorbidities. A total of 218 COVID-19-positive patients from March 18, 2020, to April 8, 2020, with a malignant diagnosis were identified. A total of 61 (28%) patients with cancer died from COVID-19 with a case fatality rate (CFR) of 37% (20/54) for hematologic malignancies and 25% (41/164) for solid malignancies. Six of 11 (55%) patients with lung cancer died from COVID-19 disease. Increased mortality was significantly associated with older age, multiple comorbidities, need for ICU support, and elevated levels of D-dimer, lactate dehydrogenase, and lactate in multivariate analysis. Age-adjusted CFRs in patients with cancer compared with noncancer patients at our institution and New York City reported a significant increase in case fatality for patients with cancer. These data suggest the need for proactive strategies to reduce likelihood of infection and improve early identification in this vulnerable patient population. SIGNIFICANCE: COVID-19 in patients with cancer is associated with a significantly increased risk of case fatality, suggesting the need for proactive strategies to reduce likelihood of infection and improve early identification in this vulnerable patient population.This article is highlighted in the In This Issue feature, p. 890 | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Goel, Sanjay |e verfasserin |4 aut | |
| 700 | 1 | |a Kabarriti, Rafi |e verfasserin |4 aut | |
| 700 | 1 | |a Cole, Daniel |e verfasserin |4 aut | |
| 700 | 1 | |a Goldfinger, Mendel |e verfasserin |4 aut | |
| 700 | 1 | |a Acuna-Villaorduna, Ana |e verfasserin |4 aut | |
| 700 | 1 | |a Pradhan, Kith |e verfasserin |4 aut | |
| 700 | 1 | |a Thota, Raja |e verfasserin |4 aut | |
| 700 | 1 | |a Reissman, Stan |e verfasserin |4 aut | |
| 700 | 1 | |a Sparano, Joseph A |e verfasserin |4 aut | |
| 700 | 1 | |a Gartrell, Benjamin A |e verfasserin |4 aut | |
| 700 | 1 | |a Smith, Richard V |e verfasserin |4 aut | |
| 700 | 1 | |a Ohri, Nitin |e verfasserin |4 aut | |
| 700 | 1 | |a Garg, Madhur |e verfasserin |4 aut | |
| 700 | 1 | |a Racine, Andrew D |e verfasserin |4 aut | |
| 700 | 1 | |a Kalnicki, Shalom |e verfasserin |4 aut | |
| 700 | 1 | |a Perez-Soler, Roman |e verfasserin |4 aut | |
| 700 | 1 | |a Halmos, Balazs |e verfasserin |4 aut | |
| 700 | 1 | |a Verma, Amit |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancer discovery |d 2011 |g 10(2020), 7 vom: 01. Juli, Seite 935-941 |w (DE-627)NLM215937023 |x 2159-8290 |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2020 |g number:7 |g day:01 |g month:07 |g pages:935-941 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1158/2159-8290.CD-20-0516 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2020 |e 7 |b 01 |c 07 |h 935-941 | ||